Non-response to Communication Technology Outreach for Beta-agonist Overuse in a Pragmatic Randomized Trial of Patients with Asthma

Non-response to Communication Technology Outreach for Beta-agonist Overuse in a Pragmatic... Non-response to Communication Technology Outreach for Beta-agonist Overuse in a Pragmatic Randomized Trial of Patients with Asthma 1,2 1 1 Marsha A. Raebel, PharmD , Susan M. Shetterly, MS , Glenn K. Goodrich, MS , 1 1 1 Courtney B. Anderson, MPH , Jo Ann Shoup, PhD , Nicole Wagner, MPH , and Bruce G. Bender, PhD 1 2 Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA; Division of Pediatric Behavioral Health, National Jewish Health, Denver, CO, USA. KEY WORDS: asthma; outreach; beta-agonist; response; pragmatic trial; symptoms is important, but unavailable to the ACC until after communication technology; telephone; electronic. s/he contacts the patient. The electronic outreach was designed to determine whether the patient currently had symptoms to J Gen Intern Med 33(6):809–11 DOI: 10.1007/s11606-018-4395-9 guide further contact. © Society of General Internal Medicine 2018 The study included members aged ≥ 18 diagnosed with persistent asthma and without chronic obstructive pulmonary disease. Patients were randomized 1:1 to receive a question about symptoms by text/call (call if phone was not text- INTRODUCTION enabled) or email if they overfilled from 2/9/2017 through Evidence suggests that communication http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of General Internal Medicine Springer Journals

Non-response to Communication Technology Outreach for Beta-agonist Overuse in a Pragmatic Randomized Trial of Patients with Asthma

Loading next page...
 
/lp/springer_journal/non-response-to-communication-technology-outreach-for-beta-agonist-MxTdd4eHQK
Publisher
Springer US
Copyright
Copyright © 2018 by Society of General Internal Medicine
Subject
Medicine & Public Health; Internal Medicine
ISSN
0884-8734
eISSN
1525-1497
D.O.I.
10.1007/s11606-018-4395-9
Publisher site
See Article on Publisher Site

Abstract

Non-response to Communication Technology Outreach for Beta-agonist Overuse in a Pragmatic Randomized Trial of Patients with Asthma 1,2 1 1 Marsha A. Raebel, PharmD , Susan M. Shetterly, MS , Glenn K. Goodrich, MS , 1 1 1 Courtney B. Anderson, MPH , Jo Ann Shoup, PhD , Nicole Wagner, MPH , and Bruce G. Bender, PhD 1 2 Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA; Division of Pediatric Behavioral Health, National Jewish Health, Denver, CO, USA. KEY WORDS: asthma; outreach; beta-agonist; response; pragmatic trial; symptoms is important, but unavailable to the ACC until after communication technology; telephone; electronic. s/he contacts the patient. The electronic outreach was designed to determine whether the patient currently had symptoms to J Gen Intern Med 33(6):809–11 DOI: 10.1007/s11606-018-4395-9 guide further contact. © Society of General Internal Medicine 2018 The study included members aged ≥ 18 diagnosed with persistent asthma and without chronic obstructive pulmonary disease. Patients were randomized 1:1 to receive a question about symptoms by text/call (call if phone was not text- INTRODUCTION enabled) or email if they overfilled from 2/9/2017 through Evidence suggests that communication

Journal

Journal of General Internal MedicineSpringer Journals

Published: Mar 12, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off